Home Ansa Biotechnologies

Ansa Biotechnologies

In operation
Series B
DNA Synthesis Technology Developer
Basic
Enterprise Profile

Basic Information

Ansa Biotechnologies is building faster and cheaper DNA synthesis services to accelerate synthetic biology research. Ansa's core technology is a novel enzyme-based DNA synthesis method that will be faster, cleaner, and more accurate than existing methods. This unique approach, developed by the founders at UC Berkeley, uses a template-independent engineered polymerase conjugated with a trinucleotide molecule, enabling the rapid construction of DNA sequences one base at a time.
Ansa Biotechnologies, Inc.
Berkeley,California,United States of America
less than 15 people
January 01, 2018
info@ansabio.com

Enterprise Profile

Industrial Sector
Biomanufacturing New Drug Development Biological Product Manufacturing
Technology
Biotechnology Genetic Engineering Synthetic Biology Enzymatic Process
Concept
Disease Treatment
Application Scenarios
Drug Concepts